Search for Clinical Trial Results

Polyradiculoneuropathy - 50 Studies Found
Status | Study |
Completed |
Study Name: Subcutaneous Immunoglobulin Treatment of Patients With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) Condition: Polyradiculoneuropathy, Chronic Inflammatory Demyelinating Date: 2009-11-06 Interventions: Drug: Subcutaneous immunoglobulin The subcutaneous immunoglobulin is infused in the subcutaneous tissue |
Completed |
Study Name: Evaluate Efficacy and Safety of Fingolimod 0.5 mg Orally Once Daily Versus Placebo in Chronic Inflammatory Demyelinating Polyradiculoneuropathy Patients. Condition: Chronic Inflammatory Demyelinating Polyradiculoneuropathy Date: 2012-06-19 Interventions:
|
Completed |
Study Name: Safety and Efficacy of Avonex in Subjects With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) Condition: Chronic Inflammatory Demyelinating Polyradiculoneuropathy Date: 2004-12-15 Interventions: Drug: Interferon Beta-1a |
Completed |
Study Name: Study of CIDP Patients During IVIG Treatment Condition: Polyradiculoneuropathy, Chronic Inflammatory Demyelinating Date: 2006-03-20 Interventions: Drug: intravenous gammaglobulin individual dose |
Recruiting |
Study Name: Phase III Efficacy, Safety, and Tolerability Study of HYQVIA/HyQvia and GAMMAGARD LIQUID/KIOVIG in CIDP Condition: Chronic Inflammatory Demyelinating Polyradiculoneuropathy Date: 2015-09-11 Interventions:
|
Not yet recruiting |
Study Name: Exploratory Study of Predictive Markers of the Therapeutic Response in Patients With Chronic Inflammatory Demyelinating Polyradiculoneuropathy Treated With Intravenous Immunoglobulin Condition: Chronic Inflammatory Demyelinating Polyradiculoneuropathy Date: 2016-08-29 Interventions:
|
Completed |
Study Name: MRI in Diagnosing and Monitoring CIDP Condition: Chronic Inflammatory Demyelinating Polyradiculoneuropathy Date: 2013-12-06 |
Recruiting |
Study Name: Efficacy and Safety Study of I10E in Treatment of Patients With CIDP Condition: Chronic Inflammatory Demyelinating Polyradiculoneuropathy Date: 2014-11-13 Interventions: Drug: I10E Patients who meet all eligibility criteria will |
Recruiting |
Study Name: Efficacy and Safety Study of I10E in the Maintenance Treatment of Patients With CIDP: Extension of PRISM Study I10E-1302 Condition: Chronic Inflammatory Demyelinating Polyradiculoneuropathy Date: 2014-12-11 Interventions: Drug: I10E Patients who met all eligibility criteria will receive 0.5 g/kg of IMP every 3 weeks during 4 |
Recruiting |
Study Name: Long-Term Tolerability and Safety of HYQVIA/HyQvia in CIDP Condition: Chronic Inflammatory Demyelinating Polyradiculoneuropathy Date: 2016-11-02 Interventions: Biological: HYQVIA Other Names:
|